Hearing: “Medicines and IP: Balancing Innovation and Access”

Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet (Committee on the Judiciary)

2141 RHOB
Washington, D.C.

Witnesses

Support Documents

• An opinion from the Supreme Court of the United States in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., submitted for the Record by Mr. Issa of CA [PDF] Added 06/04/2026 at 01:28 PM
• A study from the United States Patent and Trademark Office titled, “Drug Patent and Exclusivity Study”, submitted for the Record by Mr. Kiley of CA [PDF] Added 06/04/2026 at 01:28 PM
• A statement for the record from the Biotechnology Innovation Organization, submitted for the Record by Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A letter dated June 3, 2026, from Alliance for Aging Research to Representatives Issa and Johnson regarding the ETHIC Act, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from AARP, submitted for the Record by Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the American Society of Health-System Pharmacists (ASHP), submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the Biosimilars Forum, submitted for the Record by Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the Council for Innovation Promotion, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A brief from the Center for American Principles titled, “Cap Issue Brief: Biopharmaceutical Patents”, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the Center for American Principles, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the Center for Medicine in the Public Interest, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the Campaign for Sustainable Rx Pricing, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the ERISA Industry Committee (ERIC), submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from Families USA, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from Luis Abinader of Generation Patient, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from Peyton Miles of Generation Patient, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the National Association of Manufacturers, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from Patients for Affordable Drugs Now, submitted for the Record by Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A statement for the record from the U.S. Chamber of Commerce regarding the ETHIC Act, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A letter dated June 2, 2026, from the Alliance of U.S. Startups and Inventors for Jobs (USIJ) regarding the ETHIC Act, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/05/2026 at 12:07 PM
• A letter dated June 2, 2026, from the Intellectual Property Owners Association to Representatives Issa and Johnson regarding the ETHIC Act, submitted for the Record by Mr. Issa of CA and Mr. Johnson of GA [PDF] Added 06/09/2026 at 08:57 AM
• A letter dated June 1, 2026, from the Taxpayers Protection Alliance to Representatives Issa and Johnson regarding the hearing on June 4, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A letter dated June 3, 2026, from the American Intellectual Property Law Association to Representatives Issa and Johnson, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A copy of HR 3269, the ETHIC Act, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A copy of HR 6485, the Skinny Labels, Big Savings Act, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from Blood Cancer United, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from Representative Arrington of Texas, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from NFIB, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from multiple organizations expressing support for the ETHIC Act, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A letter dated April 6, 2026, from multiple organizations to Chairman Jordan, Ranking Member Raskin, and Representatives Issa and Johnson regarding the ETHIC Act and the Skinny Labels, Big Savings Act, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from the Pharmaceutical Care Management Association, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from the Pacific Research Institute, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from We Work for Health, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from Dr. Anne Pritchett, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from Biocom, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from Public Citizen, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from the Association for Accessible Medicines and its Biosimilars Council (AAM), submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A statement for the record from the U.S. Public Interest Research Group, submitted for the Record by Mr. Issa of CA [PDF] Added 06/09/2026 at 03:25 PM
• A study by Rachel Goode and Bernard Chao titled, "Biological patent thickets and delayed access to biosimilars, an American problem" [PDF] Added 06/11/2026 at 02:07 PM
• A statement for the record from Dr. Rachel Goode regarding the ETHIC Act [PDF] Added 06/11/2026 at 02:07 PM
• A study titled, "Biological Patent Thickets and Terminal Disclaimers" [PDF] Added 06/11/2026 at 02:07 PM
• A study from the University of Pittsburgh Law Review titled, "The Long Con: An Empirical Analysis of Pharmaceutical Patent Thickets" [PDF] Added 06/11/2026 at 02:07 PM

First Published: May 28, 2026 at 08:38 AM
Last Updated: June 11, 2026 at 02:07 PM